Insider Transactions in Q1 2025 at Avrobio, Inc. (AVRO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2025
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
660,000
+40.49%
|
$33,000,000
$50.0 P/Share
|
|
Feb 05
2025
|
Timothy A Springer |
BUY
Open market or private purchase
|
Direct |
129,294
+2.97%
|
$6,981,876
$54.14 P/Share
|
|
Feb 05
2025
|
Daniel Lochner Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,617
+50.0%
|
$249,318
$54.14 P/Share
|
|
Feb 04
2025
|
Alise Reicin Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,047
+14.4%
|
-
|
|
Feb 04
2025
|
Marcella K. Ruddy Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,876
+26.36%
|
-
|
|
Feb 04
2025
|
Daniel Lochner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,074
+50.0%
|
-
|
|
Feb 04
2025
|
Marc Schwabish Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,023
+42.82%
|
-
|
|
Feb 04
2025
|
Peter Mc Namara Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,141
+34.05%
|
-
|
|
Jan 28
2025
|
Marc Schwabish Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,700
+36.49%
|
$5,400
$2.38 P/Share
|